Interleukin-7 (IL-7) is required for T cell development in mice and humans and is produced by stromal tissues rather than activated lymphocytes. Under normal conditions, IL-7 is a limiting resource ...

HONG KONG, Jan. 27, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting ...

Clearance of ASC50 paves the way for a Phase I trial in patients with mild-to-moderate plaque psoriasis. FDA Clears First Oral IL-17 Inhibitor from Ascletis’ AI Platform Ascletis Pharma’s ASC50 ...

Upon ETA-IL application submission, applicants can expect to receive either approval or denial of their entry into Israel within 72 hours. Several months ago, Israeli media outlets reported the ...